Clinical Trial Update: Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting results of rasagiline in early Parkinson's disease patients in China who have not been treated with levodopa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-12-23